Gaining a deep understanding of stroke, trauma and dementia
Through the use of advanced ultrasound, Neural Analytics is innovating brain health management with products that are accessible, portable and accurate.
"The creation of a convenient, quantitative assessment system for the early detection of stroke is one of our most critical needs. We believe such a diagnostic tool will transform global patient management when it becomes available. We are thrilled to be the first site in the world to begin evaluation of this promising technology, which uses ultrasound to rapidly assess blood flow in the brain and may help healthcare professionals determine if a patient is suffering a stroke."Tom Devlin, MD -Medical Director of Erlanger's Southeast Regional Stroke Center
"We need a portable tool to effectively look inside the brain and determine the extent of disease to help us significantly advance brain health in the 21st century," said Neil Martin, MD. "When approved by the FDA, these types of portable devices will revolutionize medical care by assisting physicians and first responders to quickly evaluate brain health and expedite treatment for many patients."NEIL MARTIN, MD, FAANS -NEUROSURGEON
Please visit our Studies page to learn more about Neural Analytics research.
EXPEDITE (Evaluate a NeXt Generation PortablE Diagnostic Platform for Determination and Immediate Triage of Emergency Large Vessel Stroke) is an IRB three phase clinical study program to evaluate Neural Analytics' portable monitoring platform for patients suffering an acute ischemic stroke.
We are conducting a research project on athletes who play sports with a high risk of concussion.
Every year, an estimated 3.8 million Americans experience a concussion. Symptoms that usually reflect concussion may include headaches, nausea, difficulty in concentrating, etc. But since other conditions such as dehydration or chronic pain have symptoms similar to it, a concussion can often go unnoticed.